Ectin Research AB

Oncopeptides AB

This biotech company develops targeted therapies for patients with difficult-to-treat hematological diseases, specifically focusing on multiple myeloma treatments.

APIM Therapeutics AS

This clinical-stage biotechnology company develops peptide drugs targeting cellular stress responses to treat patients with advanced solid tumours and multiple cancers.

Alligatorbioscience

This biotechnology company develops antibody-based medicines for cancer treatment for patients with metastatic tumours.

CG Oncology

This biopharmaceutical company develops oncolytic immunotherapies for patients with non-muscle invasive bladder cancer.

Aura Biosciences

This biotechnology company develops virus-like drug conjugates to treat patients with solid tumours, specifically targeting ocular and bladder cancers.

Actym Therapeutics

This biotechnology company develops bacterial immunotherapies to treat solid tumours and fibrotic diseases for patients with advanced cancers.

ArTara Therapeutics

This clinical-stage biopharmaceutical company develops cell therapies and replacement treatments for patients with non-muscle invasive bladder cancer and rare metabolic diseases.

AbilityPharma

This company develops autophagy-inducing oral therapies for patients with various forms of cancer, including pancreatic, endometrial and lung cancer.